Pivotal SOLVE-CRT Trial Meets Endpoints: Excellent Interim Analysis Results Lead to Early Trial Halt for Success

SOLVE-CRT found the WiSE CRT System can safely deliver leadless CRT for previously untreatable or high-risk patients.